Institute for Protein Innovation
Timothy A. Springer, Ph.D. is the Latham Family Professor at Harvard Medical School and Boston Children’s Hospital. A world leader in structural biology and immunology, he is also a founder and private investor in ventures including LeukoSite, Scholar Rock, Morphic Therapeutic, Moderna Therapeutic, Editas Medicine, Selecta Biosciences and Ab Initio Biotherapeutics. His research and entrepreneurship have to six FDA-approved drugs.
This person is not in the org chart
Institute for Protein Innovation
The Institute for Protein Innovation is a 501(c)(3) non-profit that aims to reignite the field of protein science as a means to realize the promise of genomics to advance biology and promote human health.